Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06436261 · ClinicalTrials.gov registry record · NA

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation

A NA study, sponsored by Revision Skincare.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT06436261 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06436261, a NA study, has completed, sponsored by Revision Skincare.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This randomized, multi-center, double-blinded, split-face, controlled clinical trial was conducted to investigate the tolerability, safety, and efficacy of a post-procedure cream when used immediately after hybrid-fractional laser treatment and for 7 days post-procedure with three times daily application in healthy female subjects aged 35-65 years with moderate to severe global face photodamage (score of 4 to 7 out of the 10-point Modified Griffiths' scale). Furthermore, this clinical trial compared the active post-procedure cream to a comparator moisturizer often paired with skin rejuvenation procedures. This is a cosmetic study with an FDA-regulated device. A total of 16 healthy female subjects completed the study (8 subjects at both sites).

Interventions

  • OTHER Facial Cleanser
  • OTHER Facial Moisturizer
  • OTHER Sunscreen
  • PROCEDURE Hybrid Fractional Laser

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-12-14
Est. Completion 2022-07-01
Phase NA

Sponsor

Revision Skincare

18 total trials

What the Registry Record Tells You About NCT06436261

The ClinicalTrials.gov registry entry for NCT06436261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Facial Cleanser is the first listed.

NCT06436261 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06436261 about?

NCT06436261 is a clinical study titled "Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation". This randomized, multi-center, double-blinded, split-face, controlled clinical trial was conducted to investigate the tolerability, safety, and efficacy of a post-procedure cream when used immediately after hybrid-fractional laser treatment and for 7 days post-procedure with three times daily applic...

What is the current status of trial NCT06436261?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-12-14. Estimated completion is 2022-07-01.

What interventions are being tested in trial NCT06436261?

The interventions under investigation include: Facial Cleanser (OTHER), Facial Moisturizer (OTHER), Sunscreen (OTHER), Hybrid Fractional Laser (PROCEDURE).

Who is sponsoring clinical trial NCT06436261?

This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.